Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Oncology Biosimilars Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F
... Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F Global Oncology Biosimilars Market was valued at USD 3.27 Billion in 2023 and is anticipated ... Read More
-
Biosimilars and Follow-On Biologics Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Demand of Drugs For Treating ... Read More
-
Global Interchangeable Biosimilars Market Growth 2024-2030
... have minor differences in composition, quality, purity and biological activity compared to the reference biological drug, but these differences do not affect their efficacy or safety. Interchangeable biosimilars are generally considered to be effective alternatives ... Read More
-
Generic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Small Molecule Generics and Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House and Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region and Competition, 2019-2029F
... Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House and Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region and Competition, 2019-2029F Global Generic Drugs Market ... Read More
-
Global Pharmaceutical Continuous Manufacturing
... adoption in specific areas such as small molecule oral solid dosage forms and large molecules, the market has consistently demonstrated robust year-on-year growth. Projections indicate that the global pharmaceutical continuous manufacturing market will experience a ... Read More
-
2024 Global Forecast for Biosimilar Contract Manufacturing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
PEGylated Proteins Market
... the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed ... Read More
-
Global Erythropoietin Drugs Databank Market Report
... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global oncology biosimilars market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion ... Read More
-
Biosimilars Market based on by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook– Global Forecast up to 2032
... a high priority on the development of biosimilars. By December 2022, 25 biosimilars had been introduced in the US and 40 had received FDA approval. FDA approvals fell off dramatically during the COVID-19 pandemic, but ... Read More
-
Aseptic Connectors Market - A Global and Regional Analysis: Focus on Type, Product, End User and Region - Analysis and Forecast, 2023-2033
... at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033. The global aseptic connectors market is a dynamic and rapidly evolving ... Read More
-
2024 Global: Biosimilars Market - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
2024 Global: Biosimilar Monoclonal Antibodies Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global Forecast for Bioprocess Containers Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Traumatic Brain Injury Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Acetylcholinesterase Inhibitors, Erythropoietin, Growth Hormone, Stem Cells, Others), By Application (Local TBI, Open TBI, Closed TBI, Diffuse TBI, Primary TBI, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Traumatic Brain Injury Therapeutics market size is poised to register 5.56% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
mAb Biosimilars Market Size, Trends, Analysis, and Outlook By Type (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication (Oncology, Autoimmune diseases, Others), By End-User (Hospitals, Cancer Treatment centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global mAb Biosimilars market size is poised to register 8.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mAb ... Read More
-
Oncology Biosimilars Market Size, Trends, Analysis, and Outlook By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer, Others), By Drug Class (Monoclonal Antibodies, Granulocyte Colony-Stimulating Factor, Others), By Route of Administration (Intravenous, Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others), by Region, Country, Segment, and Companies, 2024-2030
... Subcutaneous, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Oncology Biosimilars market size is poised to register 8.84% growth (CAGR) from 2024 to 2030, presenting significant ... Read More
-
Biologics Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Biologics, Biosimilars), By Application (Outsourced, In-house), by Region, Country, Segment, and Companies, 2024-2030
... (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biologics Manufacturing market By Type (Biologics, Biosimilars), By Application (Outsourced, In-house). In biologics manufacturing, ... Read More
-
Global Glycosylated Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Glycosylated Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Glycosylated Biosimilars ... Read More
-
Global Peptides Biosimilars Market Growth (Status and Outlook) 2024-2030
... market, the Peptides Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Peptides Biosimilars ... Read More
-
Global Recombinant Non-Glycosylated Proteins Biosimilars Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Recombinant Non-Glycosylated Proteins Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Biosimilars & Follow-on-Biologics Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Biosimilars & Follow-on-Biologics is forecast to a readjusted size of US$ 60550 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential ... Read More
Research Assistance
